These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24302411)

  • 21. Prevalence and determinants in cytology testing for cervical cancer screening in Spain (2006-14).
    Cobo-Cuenca AI; Rodríguez-Borrego MA; Hidalgo-Lópezosa P; Rodríguez-Muñoz PM; Martins M; Carmona-Torres JM
    Eur J Public Health; 2018 Jun; 28(3):410-415. PubMed ID: 29444273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance.
    Hoyer H; Mehlhorn G; Scheungraber C; Hagemann I; Hirchenhain C; Woelber L; Stolte C; Hampl M; Scherbring S; Denecke A; Bartels J; Ebert AD; Meneder S; Petzold A; Heller T; Heidtke KR; Schwarz E; Stübs F; Schütze S; Stange EL; Jaeger A; Martignoni F; Dellmann A; Rody A; Hillemanns P; Fehm T; Petry KU; Böhmer G; Schmalfeldt B; Wimberger P; Beckmann MW; Runnebaum IB; Dürst M
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions.
    Mariani L; Sandri MT; Preti M; Origoni M; Costa S; Cristoforoni P; Bottari F; Sideri M
    J Cancer; 2016; 7(1):107-14. PubMed ID: 26722366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic Comparison of Different Meta-analyses, Systematic Reviews and HTA Reports on Cervical Cancer Screening based on Cytology or HPV Test.
    Jentschke M; Hillemanns P
    Geburtshilfe Frauenheilkd; 2016 Oct; 76(10):1081-1085. PubMed ID: 27761029
    [No Abstract]   [Full Text] [Related]  

  • 25. Incidence and survival trends of cervical adenocarcinoma in Italy: Cytology screening has become more effective in downstaging the disease but not in detecting its precursors.
    Mancini S; Ravaioli A; Giuliani O; Vattiato R; Falcini F; Ferretti S; Costa S; Bucchi L
    Int J Cancer; 2017 Jan; 140(1):247-248. PubMed ID: 27639249
    [No Abstract]   [Full Text] [Related]  

  • 26. Has cytology become obsolete as a primary test in screening for cervical cancer?
    Sasieni P
    J Med Screen; 2010; 17(1):2-3. PubMed ID: 20356937
    [No Abstract]   [Full Text] [Related]  

  • 27. The Influence of Vaginal HPV Self-Sampling on the Efficacy of Populational Screening for Cervical Cancer-An Umbrella Review.
    Tatara T; Wnuk K; Miazga W; Świtalski J; Karauda D; Mularczyk-Tomczewska P; Religioni U; Gujski M
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative accuracy of anal and cervical cytology in screening for moderate to severe dysplasia by magnification guided punch biopsy: a meta-analysis.
    Mathews WC; Agmas W; Cachay E
    PLoS One; 2011; 6(9):e24946. PubMed ID: 21949801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes to cervical cancer screening in Germany].
    Starrach T; Gallwas J; Blankenstein T; Mahner S; Dannecker C
    MMW Fortschr Med; 2018 Feb; 160(2):46-51. PubMed ID: 29417509
    [No Abstract]   [Full Text] [Related]  

  • 30. Self-sampling HPV DNA test for cervical cancer screening in Singapore: A prospective study.
    Lim LM; Chan MFG; Win PPT; Shen L; Arunachalam I; Ng SYJ; Low JHJ
    Ann Acad Med Singap; 2022 Nov; 51(11):733-735. PubMed ID: 36453220
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic value of human papillomavirus cell-free DNA in cervical cancer patients: A systematic review and meta-analysis.
    Wang ZY; Li R; Li RZ; Pei KG; Sun LF; Wang HJ
    Eur J Obstet Gynecol Reprod Biol; 2024 Sep; 300():211-218. PubMed ID: 39029243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discussion on cervical cytology in postmenopausal women.
    Campaner AB; Fernandes GL
    Minerva Obstet Gynecol; 2023 Oct; ():. PubMed ID: 37877942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening: Cervical cancer--should we abandon cytology for screening?
    Meijer CJ; Berkhof J
    Nat Rev Clin Oncol; 2012 Oct; 9(10):558-9. PubMed ID: 22965150
    [No Abstract]   [Full Text] [Related]  

  • 34. An emerging paradigms on cervical cancer screening methods and devices for clinical trails.
    Raimond K; Rao GB; Juliet S; Tamilarasi SRG; Evangelin PS; Mathew L
    Front Public Health; 2022; 10():1030304. PubMed ID: 36388384
    [No Abstract]   [Full Text] [Related]  

  • 35. Useful indices in evaluating a cervical cytology program.
    Handy VH; Klein P
    Public Health Rep (1896); 1967 May; 82(5):461-4. PubMed ID: 4960762
    [No Abstract]   [Full Text] [Related]  

  • 36. Correction:
    BMJ Open; 2018 Mar; 8(3):e016700corr1. PubMed ID: 29523574
    [No Abstract]   [Full Text] [Related]  

  • 37. DNA ploidy cytometry testing for cervical cancer screening in China - letter.
    Garner DM; Guillaud MD; MacAulay CE
    Clin Cancer Res; 2010 Jul; 16(13):3517. PubMed ID: 20570931
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytology training in the European community: European Community Training Programme in Cervical Cancer Screening.
    Coleman DV
    Recent Results Cancer Res; 1993; 133():137-40. PubMed ID: 8296061
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of gynecological cancer; use of fluorescence microscopy to show nucleic acids in malignant growth.
    VON BERTALANFFY L; MASIN M; MASIN F; KAPLAN L
    Calif Med; 1957 Oct; 87(4):248-51. PubMed ID: 13460741
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.